{"gene":"GNB5","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1995,"finding":"GNB5 encodes a novel G protein β subunit (Gβ5) containing five WD-40 repeat units homologous to β-transducin, with a highly acidic amino terminus and proline-rich domain; it is preferentially expressed in testes in adult tissues.","method":"cDNA cloning, sequence analysis, Northern hybridization","journal":"Mammalian genome","confidence":"Medium","confidence_rationale":"Tier 2 — foundational molecular characterization by cDNA cloning and domain analysis, single lab","pmids":["7613025"],"is_preprint":false},{"year":2000,"finding":"The flailer mouse mutation produces a hybrid protein combining the N-terminal 83 amino acids of Gnb5 with the C-terminal globular tail domain of Myosin 5A (MyoVA), formed by germ-line exon shuffling. This hybrid protein acts as a dominant negative by competing with wild-type MyoVA, preventing smooth endoplasmic reticulum vesicle localization to dendritic spines of cerebellar Purkinje cells.","method":"Genetic mapping, biochemical characterization, in vivo competition assay, cerebellar cell biology","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 — genetic epistasis, biochemical studies, and cellular localization phenotype in multiple orthogonal experiments","pmids":["10749990"],"is_preprint":false},{"year":2016,"finding":"GNB5 loss-of-function mutations cause sinus-node dysfunction, indicating a direct role of Gβ5 in cardiac heart rate control; zebrafish gnb5 knockouts recapitulated cardiac, neurological, and ophthalmological abnormalities.","method":"Zebrafish knockout, human genetics (loss-of-function alleles vs. missense variants), electrocardiographic phenotyping","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — in vivo zebrafish KO with multiple phenotypic readouts, replicated in human patients","pmids":["27523599"],"is_preprint":false},{"year":2016,"finding":"The GNB5 S81L missense variant impairs Gβ5 protein expression, reducing its ability to stabilize RGS (regulator of G protein signaling) complexes and thereby impairing termination of dopamine receptor-elicited responses.","method":"Exome sequencing, functional assay for dopamine receptor signaling deactivation, protein expression analysis","journal":"Genome biology","confidence":"Medium","confidence_rationale":"Tier 2 — functional signaling assay with defined molecular mechanism, single lab","pmids":["27677260"],"is_preprint":false},{"year":2018,"finding":"Exogenous expression of Gβ5 enhances store-operated calcium entry (SOCE) in a STIM1-dependent manner; a STIM1-ERM truncation mutant abolished enhancement, while an ORAI1 loss-of-function mutant did not inhibit Gβ5-induced SOCE.","method":"Exogenous overexpression, calcium imaging, dominant-negative and truncation mutant analysis","journal":"The Korean journal of physiology & pharmacology","confidence":"Low","confidence_rationale":"Tier 3 — single lab, single method set, no reciprocal validation","pmids":["29719456"],"is_preprint":false},{"year":2019,"finding":"The GNB5 p.S81L variant causes bradycardia by augmenting cholinergic response: homozygous hiPSC-derived cardiomyocytes showed increased acetylcholine-activated potassium current (IK,ACh) density and more pronounced decrease in spontaneous activity upon carbachol treatment; the IK,ACh blocker XEN-R0703 nearly reversed the phenotype.","method":"CRISPR/Cas9 isogenic hiPSC lines, patch-clamp electrophysiology, pharmacological rescue","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 1-2 — isogenic CRISPR lines with electrophysiology and pharmacological rescue, strong mechanistic clarity","pmids":["31208990"],"is_preprint":false},{"year":2019,"finding":"GNB5 biallelic loss-of-function causes a dual retinal signaling defect, consistent with bradyopsia (cone phototransduction recovery deficit) and rod ON-bipolar cell dysfunction, as demonstrated by extended ERG protocol in a patient with a homozygous null GNB5 mutation.","method":"Full-field electroretinography (ERG), whole-exome sequencing, extended ISI protocol","journal":"Documenta ophthalmologica","confidence":"Medium","confidence_rationale":"Tier 2 — functional retinal electrophysiology in patient with confirmed null mutation, single case","pmids":["31720979"],"is_preprint":false},{"year":2021,"finding":"A homozygous GNB5 L307R missense variant abolishes function of Gβ5S-containing RGS complexes in deactivating D2 dopamine receptor activity, as shown by bioluminescence resonance energy transfer (BRET) assay, confirming Gβ5's role in GPCR deactivation via RGS complexes.","method":"BRET assay, patient-derived fibroblast protein expression analysis, exome sequencing","journal":"Genes","confidence":"Medium","confidence_rationale":"Tier 1-2 — BRET-based functional assay for receptor deactivation with mutant validation, single lab","pmids":["34573334"],"is_preprint":false},{"year":2024,"finding":"Gnb5 heterozygosity enhances formation of amyloid plaques and neurofibrillary tangles in AD model mice, supporting Gβ5 as a modulator of AD-related pathology.","method":"Mouse genetic model (Gnb5 heterozygous), brain histopathology in AD model mice","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic model with defined pathological readout, single lab","pmids":["38354736"],"is_preprint":false},{"year":2025,"finding":"Gnb5 directly interacts with BACE1 and negatively regulates BACE1-mediated APP processing and Aβ generation; the first WD domain of Gnb5 and the Ser81 residue are critical for this regulation, and AAV-mediated hippocampal overexpression of Gnb5 reduced Aβ deposition and ameliorated cognitive deficits in 5xFAD mice.","method":"Co-immunoprecipitation (Gnb5–BACE1 interaction), conditional knockout, AAV overexpression, domain/point-mutation analysis (WD1 domain, S81L), Aβ deposition assay, cognitive behavioral testing","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including KO, AAV rescue, domain mapping, mutagenesis, and biochemical interaction in a single study","pmids":["40587559"],"is_preprint":false}],"current_model":"GNB5 encodes Gβ5, an atypical G protein β subunit that forms constitutive complexes with RGS proteins to deactivate GPCR signaling (including dopamine and muscarinic receptors); it negatively regulates IK,ACh to control cardiac pacemaking, modulates store-operated calcium entry via STIM1, and directly interacts with BACE1 through its WD1 domain to suppress amyloid precursor protein processing, while loss-of-function mutations cause a multisystem disorder (IDDCA) encompassing bradycardia, intellectual disability, retinal dysfunction, and epilepsy."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing that GNB5 encodes a structurally divergent Gβ subunit with WD-40 repeats, an acidic N-terminus, and a proline-rich domain answered whether the Gβ family contained additional members beyond the known Gβ1–4.","evidence":"cDNA cloning, sequence analysis, and Northern blot in human tissues","pmids":["7613025"],"confidence":"Medium","gaps":["No binding partners or signaling functions were identified","Expression pattern limited to Northern blot of adult tissues","No in vivo loss-of-function data"]},{"year":2000,"claim":"The flailer mouse showed that Gnb5 genomic sequences can participate in exon-shuffling events generating dominant-negative fusion proteins, but this reflected a gain-of-function artifact rather than native Gβ5 biology.","evidence":"Genetic mapping and biochemical characterization of a Gnb5–Myo5a hybrid in mouse cerebellum","pmids":["10749990"],"confidence":"High","gaps":["The flailer phenotype derives from MyoVA disruption, not Gβ5 loss-of-function","Endogenous Gβ5 signaling function remained uncharacterized","No human disease link established"]},{"year":2016,"claim":"Human GNB5 loss-of-function mutations and zebrafish gnb5 knockouts demonstrated that Gβ5 is required for cardiac pacemaker function, neurological development, and retinal signaling, establishing the first causal gene–disease relationship (IDDCA).","evidence":"Zebrafish KO with electrocardiographic, neurological, and ophthalmological phenotyping; human exome sequencing with segregation","pmids":["27523599","27677260"],"confidence":"High","gaps":["Precise cardiomyocyte-level mechanism of bradycardia was unknown","Retinal electrophysiology had not been characterized in detail","Genotype–phenotype correlation for missense versus null alleles was incomplete"]},{"year":2019,"claim":"Isogenic CRISPR cardiomyocyte models and retinal ERG studies resolved the cellular mechanisms: the GNB5 S81L variant augments IK,ACh density, explaining bradycardia, while null GNB5 impairs both cone phototransduction recovery and rod ON-bipolar cell function.","evidence":"CRISPR/Cas9 hiPSC-derived cardiomyocytes with patch-clamp and pharmacological rescue (XEN-R0703); extended-protocol ERG in a patient with homozygous null mutation","pmids":["31208990","31720979"],"confidence":"High","gaps":["Whether IK,ACh is the sole cardiac effector or other currents contribute","Mechanism linking Gβ5 loss to ON-bipolar cell dysfunction not molecularly defined","Pharmacological rescue not tested in vivo"]},{"year":2021,"claim":"BRET-based functional assays showed that missense variants such as L307R abolish Gβ5S–RGS complex-mediated deactivation of D2 dopamine receptor signaling, firmly placing Gβ5 as an obligate RGS cofactor for GPCR signal termination.","evidence":"BRET assay for D2 receptor signaling deactivation with patient-derived variant analysis","pmids":["34573334"],"confidence":"Medium","gaps":["Range of GPCR pathways requiring Gβ5–RGS complexes remains incompletely mapped","Structural basis for L307R disruption not determined","Single-lab finding"]},{"year":2024,"claim":"Gnb5 haploinsufficiency enhanced amyloid plaque and neurofibrillary tangle burden in AD model mice, revealing Gβ5 as a disease modifier for Alzheimer's pathology beyond its known GPCR-deactivation role.","evidence":"Gnb5 heterozygous cross with AD mouse model, brain histopathology","pmids":["38354736"],"confidence":"Medium","gaps":["Molecular target through which Gβ5 modulates Aβ/tau was unidentified","Single AD mouse model used","Human genetic association with AD risk not established"]},{"year":2025,"claim":"Identification of BACE1 as a direct binding partner of Gβ5 resolved the molecular mechanism: Gβ5 suppresses BACE1-mediated APP cleavage via its WD1 domain, and AAV-mediated hippocampal overexpression rescued Aβ deposition and cognitive deficits in 5xFAD mice.","evidence":"Co-immunoprecipitation, conditional KO, AAV overexpression, WD1-domain and S81L point-mutation analysis, Aβ quantification, behavioral testing","pmids":["40587559"],"confidence":"High","gaps":["Whether Gβ5–BACE1 interaction occurs independently of RGS complexes is unknown","Structural basis of WD1-BACE1 contact not resolved","Therapeutic translatability of AAV-Gnb5 approach not tested beyond a single mouse model"]},{"year":null,"claim":"Key unresolved questions include whether Gβ5–RGS and Gβ5–BACE1 functions are mechanistically separable, whether STIM1-dependent SOCE modulation is physiologically relevant, and the full spectrum of GPCRs whose signaling depends on Gβ5–RGS complex deactivation.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of Gβ5–BACE1 or Gβ5–RGS complexes in native conformation","SOCE enhancement observation lacks independent replication","Neurodevelopmental pathogenesis of IDDCA beyond cardiac and retinal systems not mechanistically defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,5,7,9]}],"localization":[],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,5,7]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[5,6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,9]}],"complexes":["Gβ5–RGS complex"],"partners":["BACE1","STIM1","RGS7","MYO5A"],"other_free_text":[]},"mechanistic_narrative":"GNB5 encodes Gβ5, an atypical G protein β subunit that functions as an obligate partner of RGS proteins to deactivate GPCR signaling and as a direct regulator of amyloid precursor protein processing. Gβ5–RGS complexes terminate signaling downstream of dopamine D2 and muscarinic acetylcholine receptors; loss-of-function mutations destabilize these complexes, augmenting acetylcholine-activated potassium current (IK,ACh) in cardiomyocytes and impairing cone phototransduction recovery and rod ON-bipolar cell signaling in the retina [PMID:27523599, PMID:31208990, PMID:31720979, PMID:34573334]. Gβ5 also directly binds BACE1 through its WD1 domain to suppress Aβ generation, and Gnb5 haploinsufficiency enhances amyloid plaque and neurofibrillary tangle formation in Alzheimer's disease mouse models [PMID:40587559, PMID:38354736]. Biallelic GNB5 loss-of-function mutations cause IDDCA syndrome, a multisystem disorder featuring sinus-node bradycardia, intellectual disability, retinal dysfunction, and epilepsy [PMID:27523599, PMID:27677260]."},"prefetch_data":{"uniprot":{"accession":"O14775","full_name":"Guanine nucleotide-binding protein subunit beta-5","aliases":["Gbeta5","Transducin beta chain 5"],"length_aa":395,"mass_kda":43.6,"function":"Enhances GTPase-activating protein (GAP) activity of regulator of G protein signaling (RGS) proteins, such as RGS7 and RGS9, hence involved in the termination of the signaling initiated by the G protein coupled receptors (GPCRs) by accelerating the GTP hydrolysis on the G-alpha subunits, thereby promoting their inactivation (PubMed:27677260). Increases RGS7 GTPase-activating protein (GAP) activity, thereby regulating mood and cognition (By similarity). Increases RGS9 GTPase-activating protein (GAP) activity, hence contributes to the deactivation of G protein signaling initiated by D(2) dopamine receptors (PubMed:27677260). May play an important role in neuronal signaling, including in the parasympathetic, but not sympathetic, control of heart rate (By similarity)","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/O14775/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNB5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"FKBP8","stoichiometry":0.2},{"gene":"GNB1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/GNB5","total_profiled":1310},"omim":[{"mim_id":"617182","title":"LODDER-MERLA SYNDROME, TYPE 2, WITH DEVELOPMENTAL DELAY AND WITH OR WITHOUT CARDIAC ARRHYTHMIA; LDMLS2","url":"https://www.omim.org/entry/617182"},{"mim_id":"617173","title":"LODDER-MERLA SYNDROME, TYPE 1, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CARDIAC ARRHYTHMIA; LDMLS1","url":"https://www.omim.org/entry/617173"},{"mim_id":"615004","title":"LEUCINE-RICH REPEAT, IMMUNOGLOBULIN-LIKE, AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 3; LRIT3","url":"https://www.omim.org/entry/615004"},{"mim_id":"610890","title":"REGULATOR OF G PROTEIN SIGNALING 7-BINDING PROTEIN; RGS7BP","url":"https://www.omim.org/entry/610890"},{"mim_id":"607814","title":"REGULATOR OF G PROTEIN SIGNALING 9-BINDING PROTEIN; RGS9BP","url":"https://www.omim.org/entry/607814"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear speckles","reliability":"Approved"},{"location":"Centrosome","reliability":"Additional"},{"location":"Rods & Rings","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"retina","ntpm":111.3}],"url":"https://www.proteinatlas.org/search/GNB5"},"hgnc":{"alias_symbol":["GB5"],"prev_symbol":[]},"alphafold":{"accession":"O14775","domains":[{"cath_id":"-","chopping":"11-45","consensus_level":"medium","plddt":82.3674,"start":11,"end":45},{"cath_id":"2.130.10.10","chopping":"93-393","consensus_level":"high","plddt":96.8261,"start":93,"end":393}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14775","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14775-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14775-F1-predicted_aligned_error_v6.png","plddt_mean":94.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNB5","jax_strain_url":"https://www.jax.org/strain/search?query=GNB5"},"sequence":{"accession":"O14775","fasta_url":"https://rest.uniprot.org/uniprotkb/O14775.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14775/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14775"}},"corpus_meta":[{"pmid":"27523599","id":"PMC_27523599","title":"GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability.","date":"2016","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27523599","citation_count":57,"is_preprint":false},{"pmid":"12401210","id":"PMC_12401210","title":"Monosialyl-Gb5 organized with cSrc and FAK in GEM of human breast carcinoma MCF-7 cells defines their invasive properties.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12401210","citation_count":44,"is_preprint":false},{"pmid":"27677260","id":"PMC_27677260","title":"GNB5 mutation causes a novel neuropsychiatric disorder featuring attention deficit hyperactivity disorder, severely impaired language development and normal cognition.","date":"2016","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/27677260","citation_count":38,"is_preprint":false},{"pmid":"16995838","id":"PMC_16995838","title":"Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16995838","citation_count":25,"is_preprint":false},{"pmid":"10749990","id":"PMC_10749990","title":"The mouse neurological mutant flailer expresses a novel hybrid gene derived by exon shuffling between Gnb5 and Myo5a.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10749990","citation_count":24,"is_preprint":false},{"pmid":"31208990","id":"PMC_31208990","title":"Genetic variation in GNB5 causes bradycardia by augmenting the cholinergic response via increased acetylcholine-activated potassium current (IK,ACh).","date":"2019","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/31208990","citation_count":22,"is_preprint":false},{"pmid":"31631344","id":"PMC_31631344","title":"The epileptology of GNB5 encephalopathy.","date":"2019","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/31631344","citation_count":15,"is_preprint":false},{"pmid":"36831001","id":"PMC_36831001","title":"Anti-Inflammatory Effects of Allocryptopine via the Target on the CX3CL1-CX3CR1 axis/GNB5/AKT/NF-κB/Apoptosis in Dextran Sulfate-Induced Mice.","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/36831001","citation_count":14,"is_preprint":false},{"pmid":"31720979","id":"PMC_31720979","title":"Unique retinal signaling defect in GNB5-related disease.","date":"2019","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/31720979","citation_count":12,"is_preprint":false},{"pmid":"30631341","id":"PMC_30631341","title":"A NGS-Targeted Autism/ID Panel Reveals Compound Heterozygous GNB5 Variants in a Novel Patient.","date":"2018","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30631341","citation_count":12,"is_preprint":false},{"pmid":"32477400","id":"PMC_32477400","title":"Severe Phenotype in a Patient With Homozygous 15q21.2 Microdeletion Involving BCL2L10, GNB5, and MYO5C Genes, Resembling Infantile Developmental Disorder With Cardiac Arrhythmias (IDDCA).","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32477400","citation_count":8,"is_preprint":false},{"pmid":"38354736","id":"PMC_38354736","title":"The association of GNB5 with Alzheimer disease revealed by genomic analysis restricted to variants impacting gene function.","date":"2024","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38354736","citation_count":7,"is_preprint":false},{"pmid":"32203251","id":"PMC_32203251","title":"IDDCA syndrome in a Chinese infant due to GNB5 biallelic mutations.","date":"2020","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32203251","citation_count":4,"is_preprint":false},{"pmid":"39577216","id":"PMC_39577216","title":"ITGB4/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39577216","citation_count":4,"is_preprint":false},{"pmid":"34573334","id":"PMC_34573334","title":"Extended Phenotyping and Functional Validation Facilitate Diagnosis of a Complex Patient Harboring Genetic Variants in MCCC1 and GNB5 Causing Overlapping Phenotypes.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34573334","citation_count":3,"is_preprint":false},{"pmid":"32987464","id":"PMC_32987464","title":"[Intellectual developmental disorder with cardiac arrhythmia syndrome in a family caused by GNB5 variation and literature review].","date":"2020","source":"Zhonghua er ke za zhi = Chinese journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32987464","citation_count":2,"is_preprint":false},{"pmid":"7613025","id":"PMC_7613025","title":"The Gnb5 gene is a novel beta-transducin homolog transcribed from a divergent promoter located immediately upstream of the Syrian hamster p53 P1 promoter.","date":"1995","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/7613025","citation_count":2,"is_preprint":false},{"pmid":"29719456","id":"PMC_29719456","title":"Increased store-operated Ca2+ entry mediated by GNB5 and STIM1.","date":"2018","source":"The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29719456","citation_count":2,"is_preprint":false},{"pmid":"31479876","id":"PMC_31479876","title":"Generation of the induced human pluripotent stem cell lines CSSi009-A from a patient with a GNB5 pathogenic variant, and CSSi010-A from a CRISPR/Cas9 engineered GNB5 knock-out human cell line.","date":"2019","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31479876","citation_count":2,"is_preprint":false},{"pmid":"40565581","id":"PMC_40565581","title":"Mixed Segmental Uniparental Disomy of Chromosome 15q11-q1 Coexists with Homozygous Variant in GNB5 Gene in Child with Prader-Willi and Lodder-Merla Syndrome.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/40565581","citation_count":1,"is_preprint":false},{"pmid":"40587559","id":"PMC_40587559","title":"Gnb5 is a negative regulator of the BACE1-mediated Aβ generation and ameliorates cognitive deficits in a mouse model of Alzheimer's disease.","date":"2025","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/40587559","citation_count":0,"is_preprint":false},{"pmid":"37994112","id":"PMC_37994112","title":"Inheritance of c.628-6G>A GNB5 hypomorphic allele uncovers another challenge in the pathogenic prediction of genomic variants.","date":"2023","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37994112","citation_count":0,"is_preprint":false},{"pmid":"41382285","id":"PMC_41382285","title":"GB5, a synergistic phytotherapy for type 2 diabetes mellitus management: an integrated polyherbal approach from phytochemical profiling to network pharmacology.","date":"2025","source":"BMC complementary medicine and therapies","url":"https://pubmed.ncbi.nlm.nih.gov/41382285","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12747,"output_tokens":2249,"usd":0.035988},"stage2":{"model":"claude-opus-4-6","input_tokens":5591,"output_tokens":2297,"usd":0.12807},"total_usd":0.164058,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"GNB5 encodes a novel G protein β subunit (Gβ5) containing five WD-40 repeat units homologous to β-transducin, with a highly acidic amino terminus and proline-rich domain; it is preferentially expressed in testes in adult tissues.\",\n      \"method\": \"cDNA cloning, sequence analysis, Northern hybridization\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — foundational molecular characterization by cDNA cloning and domain analysis, single lab\",\n      \"pmids\": [\"7613025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The flailer mouse mutation produces a hybrid protein combining the N-terminal 83 amino acids of Gnb5 with the C-terminal globular tail domain of Myosin 5A (MyoVA), formed by germ-line exon shuffling. This hybrid protein acts as a dominant negative by competing with wild-type MyoVA, preventing smooth endoplasmic reticulum vesicle localization to dendritic spines of cerebellar Purkinje cells.\",\n      \"method\": \"Genetic mapping, biochemical characterization, in vivo competition assay, cerebellar cell biology\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic epistasis, biochemical studies, and cellular localization phenotype in multiple orthogonal experiments\",\n      \"pmids\": [\"10749990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GNB5 loss-of-function mutations cause sinus-node dysfunction, indicating a direct role of Gβ5 in cardiac heart rate control; zebrafish gnb5 knockouts recapitulated cardiac, neurological, and ophthalmological abnormalities.\",\n      \"method\": \"Zebrafish knockout, human genetics (loss-of-function alleles vs. missense variants), electrocardiographic phenotyping\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo zebrafish KO with multiple phenotypic readouts, replicated in human patients\",\n      \"pmids\": [\"27523599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The GNB5 S81L missense variant impairs Gβ5 protein expression, reducing its ability to stabilize RGS (regulator of G protein signaling) complexes and thereby impairing termination of dopamine receptor-elicited responses.\",\n      \"method\": \"Exome sequencing, functional assay for dopamine receptor signaling deactivation, protein expression analysis\",\n      \"journal\": \"Genome biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional signaling assay with defined molecular mechanism, single lab\",\n      \"pmids\": [\"27677260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Exogenous expression of Gβ5 enhances store-operated calcium entry (SOCE) in a STIM1-dependent manner; a STIM1-ERM truncation mutant abolished enhancement, while an ORAI1 loss-of-function mutant did not inhibit Gβ5-induced SOCE.\",\n      \"method\": \"Exogenous overexpression, calcium imaging, dominant-negative and truncation mutant analysis\",\n      \"journal\": \"The Korean journal of physiology & pharmacology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single method set, no reciprocal validation\",\n      \"pmids\": [\"29719456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The GNB5 p.S81L variant causes bradycardia by augmenting cholinergic response: homozygous hiPSC-derived cardiomyocytes showed increased acetylcholine-activated potassium current (IK,ACh) density and more pronounced decrease in spontaneous activity upon carbachol treatment; the IK,ACh blocker XEN-R0703 nearly reversed the phenotype.\",\n      \"method\": \"CRISPR/Cas9 isogenic hiPSC lines, patch-clamp electrophysiology, pharmacological rescue\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — isogenic CRISPR lines with electrophysiology and pharmacological rescue, strong mechanistic clarity\",\n      \"pmids\": [\"31208990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GNB5 biallelic loss-of-function causes a dual retinal signaling defect, consistent with bradyopsia (cone phototransduction recovery deficit) and rod ON-bipolar cell dysfunction, as demonstrated by extended ERG protocol in a patient with a homozygous null GNB5 mutation.\",\n      \"method\": \"Full-field electroretinography (ERG), whole-exome sequencing, extended ISI protocol\",\n      \"journal\": \"Documenta ophthalmologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional retinal electrophysiology in patient with confirmed null mutation, single case\",\n      \"pmids\": [\"31720979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A homozygous GNB5 L307R missense variant abolishes function of Gβ5S-containing RGS complexes in deactivating D2 dopamine receptor activity, as shown by bioluminescence resonance energy transfer (BRET) assay, confirming Gβ5's role in GPCR deactivation via RGS complexes.\",\n      \"method\": \"BRET assay, patient-derived fibroblast protein expression analysis, exome sequencing\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — BRET-based functional assay for receptor deactivation with mutant validation, single lab\",\n      \"pmids\": [\"34573334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Gnb5 heterozygosity enhances formation of amyloid plaques and neurofibrillary tangles in AD model mice, supporting Gβ5 as a modulator of AD-related pathology.\",\n      \"method\": \"Mouse genetic model (Gnb5 heterozygous), brain histopathology in AD model mice\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with defined pathological readout, single lab\",\n      \"pmids\": [\"38354736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Gnb5 directly interacts with BACE1 and negatively regulates BACE1-mediated APP processing and Aβ generation; the first WD domain of Gnb5 and the Ser81 residue are critical for this regulation, and AAV-mediated hippocampal overexpression of Gnb5 reduced Aβ deposition and ameliorated cognitive deficits in 5xFAD mice.\",\n      \"method\": \"Co-immunoprecipitation (Gnb5–BACE1 interaction), conditional knockout, AAV overexpression, domain/point-mutation analysis (WD1 domain, S81L), Aβ deposition assay, cognitive behavioral testing\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including KO, AAV rescue, domain mapping, mutagenesis, and biochemical interaction in a single study\",\n      \"pmids\": [\"40587559\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNB5 encodes Gβ5, an atypical G protein β subunit that forms constitutive complexes with RGS proteins to deactivate GPCR signaling (including dopamine and muscarinic receptors); it negatively regulates IK,ACh to control cardiac pacemaking, modulates store-operated calcium entry via STIM1, and directly interacts with BACE1 through its WD1 domain to suppress amyloid precursor protein processing, while loss-of-function mutations cause a multisystem disorder (IDDCA) encompassing bradycardia, intellectual disability, retinal dysfunction, and epilepsy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GNB5 encodes Gβ5, an atypical G protein β subunit that functions as an obligate partner of RGS proteins to deactivate GPCR signaling and as a direct regulator of amyloid precursor protein processing. Gβ5–RGS complexes terminate signaling downstream of dopamine D2 and muscarinic acetylcholine receptors; loss-of-function mutations destabilize these complexes, augmenting acetylcholine-activated potassium current (IK,ACh) in cardiomyocytes and impairing cone phototransduction recovery and rod ON-bipolar cell signaling in the retina [PMID:27523599, PMID:31208990, PMID:31720979, PMID:34573334]. Gβ5 also directly binds BACE1 through its WD1 domain to suppress Aβ generation, and Gnb5 haploinsufficiency enhances amyloid plaque and neurofibrillary tangle formation in Alzheimer's disease mouse models [PMID:40587559, PMID:38354736]. Biallelic GNB5 loss-of-function mutations cause IDDCA syndrome, a multisystem disorder featuring sinus-node bradycardia, intellectual disability, retinal dysfunction, and epilepsy [PMID:27523599, PMID:27677260].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing that GNB5 encodes a structurally divergent Gβ subunit with WD-40 repeats, an acidic N-terminus, and a proline-rich domain answered whether the Gβ family contained additional members beyond the known Gβ1–4.\",\n      \"evidence\": \"cDNA cloning, sequence analysis, and Northern blot in human tissues\",\n      \"pmids\": [\"7613025\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No binding partners or signaling functions were identified\",\n        \"Expression pattern limited to Northern blot of adult tissues\",\n        \"No in vivo loss-of-function data\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"The flailer mouse showed that Gnb5 genomic sequences can participate in exon-shuffling events generating dominant-negative fusion proteins, but this reflected a gain-of-function artifact rather than native Gβ5 biology.\",\n      \"evidence\": \"Genetic mapping and biochemical characterization of a Gnb5–Myo5a hybrid in mouse cerebellum\",\n      \"pmids\": [\"10749990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The flailer phenotype derives from MyoVA disruption, not Gβ5 loss-of-function\",\n        \"Endogenous Gβ5 signaling function remained uncharacterized\",\n        \"No human disease link established\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Human GNB5 loss-of-function mutations and zebrafish gnb5 knockouts demonstrated that Gβ5 is required for cardiac pacemaker function, neurological development, and retinal signaling, establishing the first causal gene–disease relationship (IDDCA).\",\n      \"evidence\": \"Zebrafish KO with electrocardiographic, neurological, and ophthalmological phenotyping; human exome sequencing with segregation\",\n      \"pmids\": [\"27523599\", \"27677260\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Precise cardiomyocyte-level mechanism of bradycardia was unknown\",\n        \"Retinal electrophysiology had not been characterized in detail\",\n        \"Genotype–phenotype correlation for missense versus null alleles was incomplete\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Isogenic CRISPR cardiomyocyte models and retinal ERG studies resolved the cellular mechanisms: the GNB5 S81L variant augments IK,ACh density, explaining bradycardia, while null GNB5 impairs both cone phototransduction recovery and rod ON-bipolar cell function.\",\n      \"evidence\": \"CRISPR/Cas9 hiPSC-derived cardiomyocytes with patch-clamp and pharmacological rescue (XEN-R0703); extended-protocol ERG in a patient with homozygous null mutation\",\n      \"pmids\": [\"31208990\", \"31720979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether IK,ACh is the sole cardiac effector or other currents contribute\",\n        \"Mechanism linking Gβ5 loss to ON-bipolar cell dysfunction not molecularly defined\",\n        \"Pharmacological rescue not tested in vivo\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"BRET-based functional assays showed that missense variants such as L307R abolish Gβ5S–RGS complex-mediated deactivation of D2 dopamine receptor signaling, firmly placing Gβ5 as an obligate RGS cofactor for GPCR signal termination.\",\n      \"evidence\": \"BRET assay for D2 receptor signaling deactivation with patient-derived variant analysis\",\n      \"pmids\": [\"34573334\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Range of GPCR pathways requiring Gβ5–RGS complexes remains incompletely mapped\",\n        \"Structural basis for L307R disruption not determined\",\n        \"Single-lab finding\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Gnb5 haploinsufficiency enhanced amyloid plaque and neurofibrillary tangle burden in AD model mice, revealing Gβ5 as a disease modifier for Alzheimer's pathology beyond its known GPCR-deactivation role.\",\n      \"evidence\": \"Gnb5 heterozygous cross with AD mouse model, brain histopathology\",\n      \"pmids\": [\"38354736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular target through which Gβ5 modulates Aβ/tau was unidentified\",\n        \"Single AD mouse model used\",\n        \"Human genetic association with AD risk not established\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of BACE1 as a direct binding partner of Gβ5 resolved the molecular mechanism: Gβ5 suppresses BACE1-mediated APP cleavage via its WD1 domain, and AAV-mediated hippocampal overexpression rescued Aβ deposition and cognitive deficits in 5xFAD mice.\",\n      \"evidence\": \"Co-immunoprecipitation, conditional KO, AAV overexpression, WD1-domain and S81L point-mutation analysis, Aβ quantification, behavioral testing\",\n      \"pmids\": [\"40587559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Gβ5–BACE1 interaction occurs independently of RGS complexes is unknown\",\n        \"Structural basis of WD1-BACE1 contact not resolved\",\n        \"Therapeutic translatability of AAV-Gnb5 approach not tested beyond a single mouse model\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include whether Gβ5–RGS and Gβ5–BACE1 functions are mechanistically separable, whether STIM1-dependent SOCE modulation is physiologically relevant, and the full spectrum of GPCRs whose signaling depends on Gβ5–RGS complex deactivation.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of Gβ5–BACE1 or Gβ5–RGS complexes in native conformation\",\n        \"SOCE enhancement observation lacks independent replication\",\n        \"Neurodevelopmental pathogenesis of IDDCA beyond cardiac and retinal systems not mechanistically defined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 5, 7, 9]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 5, 7]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 9]}\n    ],\n    \"complexes\": [\n      \"Gβ5–RGS complex\"\n    ],\n    \"partners\": [\n      \"BACE1\",\n      \"STIM1\",\n      \"RGS7\",\n      \"MYO5A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}